Latest Share Chat

Haleon Share News (HLN)

Haleon Information

Buy HLN Shares
Add HLN to Watchlist
Add HLN to Alert

Share Price Information for Haleon (HLN)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 324.10

Bid: 324.10

Ask: 324.30

Change: -2.80 (-0.86%)

Spread: 0.20 (0.062%)

Open: 328.50

High: 330.70

Low: 323.90

Prev. Close: 326.90

Last checked at -

Pfizer to cut stake in Haleon to 24% from 32%

Mon, 18th Mar 2024 07:35

(Sharecast News) - Consumer healthcare company Haleon said on Monday that Pfizer plans to sell around 630m shares in the company in a public offering.

The sale will reduce Pfizer's stake from 32% to approximately 24%.

Haleon - which was spun off from GSK - said the offer price per share will be determined by means of a bookbuilding process and is expected to be announced on or about 19 March, following completion.

Pfizer had said in May 2023 that it was planning to cut its stake in Haleon in a "slow and methodical" manner.

More News

6 Feb 2024 12:24

Futura Medical shares surge after "transformational year"

(Alliance News) - Futura Medical PLC on Tuesday reported its first revenues in 2023, thanks to the successful global roll-out of Eroxon.

2 Feb 2024 14:25

IN BRIEF: Mondelez appoints Haleon CEO Brian McNamara as board member

Mondelez International Inc - Chicago, Illinois-based food and beverage company - Appoints Haleon PLC's Chief Executive Officer Brian McNamara to its board from yesterday. "We are pleased to welcome Brian to our board. His breadth and depth of expertise in all aspects of consumer products leadership – including supply chain, brand marketing, customer engagement and more – will provide valuable insight and strategic input to our team," said Mondelez CEO Dirk Van de Put. McNamara’s appointment expands the size of the company's board to 11 members, adds Mondelez.

1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

30 Jan 2024 09:32

LONDON BROKER RATINGS: BoA cuts Barratt, Persimmon; ups Taylor Wimpey

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

25 Jan 2024 12:07

LONDON MARKET MIDDAY: Stocks down before expected ECB hold and US data

(Alliance News) - Stock prices in London were down at midday on Thursday, in tepid trade ahead of an expected interest rate hold from the European Central Bank and a US gross domestic product reading.

25 Jan 2024 08:47

LONDON MARKET OPEN: Stocks drift lower before ECB decision

(Alliance News) - Stock prices in London opened lower on Thursday, amidst uncertainty ahead of the European Central Bank rate call.

25 Jan 2024 08:39

TOP NEWS: Haleon sells ChapStick brand for USD430 million in cash

(Alliance News) - Haleon PLC on Thursday it has agreed to sell the ChapStick lip balm brand to Suave Brands Co for around USD430 million in cash.

25 Jan 2024 07:41

LONDON BRIEFING: Haleon sells ChapStick; RS reports market weakness

(Alliance News) - Stocks in London are called slightly lower on Thursday, ahead of a central bank decision in the eurozone, and US economic growth data.

25 Jan 2024 07:14

Haleon offloads ChapStick brand for $430m

(Sharecast News) - Consumer health group Haleon, the company behind Sensodyne toothpaste, Panadol and Advil painkillers, has announced it is selling the ChapStick lip balm brand for $430m.

24 Jan 2024 16:31

London close: Stocks rise on positive news from China

(Sharecast News) - London markets finished with a positive performance on Wednesday, driven by gains in the mining sector following China's announcement of an upcoming reduction in the reserve requirement ratio for banks.

24 Jan 2024 15:58

Broker tips: Greggs, Haleon

(Sharecast News) - Numis initiated coverage of Greggs on Wednesday with a 'hold' rating and 2,560p price target as it said growth was "baked in".

24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

24 Jan 2024 12:32

JPMorgan puts Haleon on negative catalyst watch

(Sharecast News) - JPMorgan has placed consumer health company Haleon on negative catalyst watch ahead of its annual report next month, saying volume and earnings risks will weigh on the stock's rating.

24 Jan 2024 09:11

LONDON BROKER RATINGS: UBS cuts BAT to 'neutral'; Barclays cuts Senior

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Latest Share Chat

Haleon Share News (HLN)

Share Price Information for Haleon (HLN)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pfizer to cut stake in Haleon to 24% from 32%

Login to your account

Quickpicks are a member only feature

Login to your account